Toll Free Helpline (India): 1800 1234 070
Rest of World: +91-9810852116
Free Publication Certificate
Submit Manuscript
Journal code(s)
- E-ISSN Number: 2277-7695
- P-ISSN Number: 2349-8242
- CODEN Code: PIHNBQ
- ZDB-Number: 2663038-2
- IC Journal ID: 7725
Main Menu
Special Issue
Copyright Form
Identifier
Vol. 13, Issue 4 (2024)
Health status of COVID-19 cases at health facilities of Baghdad Alkarkh health directorate from 1st March 2020 to 31st March 2023 retrospective study
Author(s):
Dr. Fawzi Hashim Atshan, Dr. Huda Hamid Mohsen, Dr. Yahya Fawzi, Dr. Ibtisam Faraj Hasan and Dr. Munir Talib Salman
Dr. Fawzi Hashim Atshan, Dr. Huda Hamid Mohsen, Dr. Yahya Fawzi, Dr. Ibtisam Faraj Hasan and Dr. Munir Talib Salman
Abstract:
Background: There are three major coronaviruses leading to disease outbreaks, beginning with the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002, followed by the Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, on December 2019 reported the 1st case of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in china and on March 2020 the WHO announced it as pandemic worldwide. On 5 May 2023, WHO stated that ’COVID-19 is now an established and ongoing health issue which no longer constitutes a public health emergency of international concern’.
Background: There are three major coronaviruses leading to disease outbreaks, beginning with the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002, followed by the Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, on December 2019 reported the 1st case of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in china and on March 2020 the WHO announced it as pandemic worldwide. On 5 May 2023, WHO stated that ’COVID-19 is now an established and ongoing health issue which no longer constitutes a public health emergency of international concern’.
Goal: To identified the Health status of COVID-19 cases at health facilities from 1st March 2020 to 31 March 2023.
Methods: Descriptive statistics are used to present data confirmed by the epidemics section of Department of Public Health in Bagdad Alkarkh health directorate, the World Health Organization, and statistical unit of involved health facilities in the study. The data included all screened and infected COVID-19 cases. Analyzed data by Excel Word-10 and summarized as tables and graphs.
Results: Total screened case (1913962) which represented (57%) of all population of Bagdad Alkarkh (3373543), total confirmed cases (383111), (377855) recovered and (3184) dead, (54% male), age group (26-35 years) (25%), about (82%) of confirmed cases are mild to moderate treated at home while severe and critical case (15%) need hospitalization the rest (3%) treated on his responsibility, recovery ratio 99% and case fatality ratio 1%., (71%) of pop with at least take one dose and (31%) full vaccination.
Conclusion: COVID-19 does not discriminate between nationalities, sexes, or ages. It is important to not let fear lead to stigma toward friends, neighbors, or members of the community. Treat all people with compassion and speak up if you hear others making statements that cause stigma against people in your community.
Pages: 159-166 | 116 Views 51 Downloads
How to cite this article:
Dr. Fawzi Hashim Atshan, Dr. Huda Hamid Mohsen, Dr. Yahya Fawzi, Dr. Ibtisam Faraj Hasan, Dr. Munir Talib Salman. Health status of COVID-19 cases at health facilities of Baghdad Alkarkh health directorate from 1st March 2020 to 31st March 2023 retrospective study. Pharma Innovation 2024;13(4):159-166. DOI: 10.22271/tpi.2024.v13.i4c.25623
Journal code(s)
- E-ISSN Number: 2277-7695
- P-ISSN Number: 2349-8242
- CODEN Code: PIHNBQ
- ZDB-Number: 2663038-2
- IC Journal ID: 7725
Main Menu
Special Issue
Copyright Form
Identifier
The Pharma Innovation Journal
